We came across a bullish thesis on TransMedics Group, Inc. on Johnny's bearish Investing’s Substack. In this article, we will summarize the bulls’ thesis on TMDX. TransMedics Group, Inc.'s share was trading at $138.97 as of January 28th. TMDX’s trailing and forward P/E were 55.51 and 58.82 respectively according to Yahoo Finance.
[caption id="attachment_570653" align="aligncenter" width="750"]TransMedics Group (TMDX) is a U.S.-based medtech company that has built a differentiated position in organ transplantation through its Organ...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.